Related Experiment Videos
Blockade of plasmid replication mediated by peptide nucleic acids
Michael R Liebling1, Nainn-Tsyr Jou, Wayne Fang
1Division of Rheumatology, Box 470/ E2 South, LAC Harbor-UCLA Medical Center,1000 West Carson Street, Torrance, CA 90509, USA. mliebling@rei.edu
Molecular Biotechnology
|December 12, 2003
Summary
Peptide nucleic acids (PNAs) can block plasmid replication in bacteria. This study demonstrates PNA
Area of Science:
- Molecular Biology
- Antimicrobial Research
- Genetics
Background:
- Peptide nucleic acids (PNAs) are DNA analogs that can bind nucleic acids.
- PNAs inhibit DNA amplification by Taq DNA polymerase in vitro.
- The potential for PNAs to inhibit replication in vivo remains largely unexplored.
Purpose of the Study:
- To investigate the efficacy of PNAs in blocking plasmid replication within living bacterial cells.
- To determine if PNAs can achieve complete replication blockade in vivo.
Main Methods:
- PNAs targeting the ampicillin resistance gene (Ampr) were designed and synthesized.
- PNAs were introduced into Escherichia coli (E. coli) cells containing pUC19 plasmids via electroporation.
- Replication blockade was assessed by ampicillin sensitivity and blue-white screening on X-gal media.
Main Results:
- PNAs successfully blocked pUC19 plasmid replication in E. coli, evidenced by ampicillin sensitivity and lack of blue color formation.
- The replication blockade effect was dose-dependent.
- Attempts to block bacterial genome replication using PNAs were less successful due to inconsistent cellular uptake.
Conclusions:
- This study provides the first evidence of complete in vivo replication blockade by PNAs.
- PNAs show potential as a novel strategy for specific antibiosis in prokaryotic and eukaryotic cells.
- Further research is needed to optimize PNA delivery for effective genome-wide inhibition.